Clinical Trial Update: Partially HLA-Matched Irradiated Allogeneic Cellular Therapy After Reduced Intensity Total Body Irradiation [Phase 1]

View source ↗

Summary

Phase 1 study of a partially HLA-matched irradiated allogeneic cellular therapy given after reduced-intensity total body irradiation; the trial in leukemia, lym…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Lymphoma
• Multiple Myeloma
• Myelodysplastic Syndromes
• Plasma Cell Neoplasms

Drugs mentioned

• Partially HLA-matched irradiated allogeneic cellular therapy

Snippet

Sponsor: University of Medicine and Dentistry of New Jersey | Conditions: Leukemia, Lymphoma | Phase 1 | Status: TERMINATED